Executives from Alphatec (NASDAQ:ATEC) outlined the company’s strategy for “long-term differentiated growth” during a presentation at a JPMorgan healthcare conference, highlighting recent financial performance, a continued emphasis on procedure-focused product design, and an expanding role for data
Alphatec Touts 2026 Growth Plan at JPMorgan Conference, Guides to $890M Revenue and $20M FCF
January 14, 2026
You may also like
Indices by TradingView
This Nuclear Energy ETF Is Quietly Powering Past the Competition
February 8, 2026
Missed Your RMD? You May Still Be Able to Avoid a Penalty.
February 8, 2026
Corning Rallies As Meta Deal And Project Vault Shape Growth Story
February 7, 2026
Categories
Indices by TradingView



